Both in Pharmaceuticals
Calamos S&P 500 Structured Alt Protection ETF - March vs Innovator U.S. Equity Ultra Buffer ETF - November
Over the past year CPSR returned +5.6% and UNOV returned +10.4%; their daily moves had a correlation of 0.81.
CPSR +5.6% UNOV +10.4%Growth of $1, one year, split-adjusted
| Metric | CPSR | UNOV |
|---|---|---|
| Price | $26.19 | $41.36 |
| Market cap | $34.0M | $106.5M |
| Today | +0.03% | −0.24% |
| 1 month | +0.3% | +0.6% |
| 6 months | +3.9% | +12.4% |
| Year to date | +3.9% | +8.7% |
| 1 year | +5.8% | +10.7% |
| Revenue growth (YoY) | −87.7% | +3.0% |
| Gross margin | 55.0% | 69.0% |
| Net margin | −693.9% | 8.0% |
| P/E (TTM) | — | 27.4× |
| Price / sales | 2.8× | 3.0× |
| Net cash | -$52.7M | $2.8M |
| Dividend yield | — | — |
| Volatility (60d) | 1.6% | 5.1% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).